Skip to main content
Press Releases

Candela and InMode Announce Settlement Of Patent Infringement Lawsuit

March 20, 2019

WAYLAND, Mass. and LAKE FOREST, Calif., March 20, 2019 /PRNewswire/ -- Syneron Medical Ltd.

Read more
Press Releases

Candela Announces Results of The Largest Published Study of Infants And Children Using Vbeam Laser System

March 14, 2019

JAMA-Dermatology publishes Dr. Roy Geronemus' authored largest study of infants and babies receiving a non-invasive treatment (vs.

Read more
Press Releases

Candela Unveils New Corporate Identity at the 2019 American Academy of Dermatology (AAD) Annual Meeting

March 1, 2019

Candela Unveils New Corporate Identity at the 2019 American Academy of Dermatology (AAD) Annual Meeting

New brand reflects commitment to Science, Results, T

Read more
Press Releases

Profound® Treatment Named "New Treatment of the Year" by MyFaceMyBody Awards USA

November 11, 2018

WAYLAND, MASSACHUSETTS, NOVEMBER 12, 2018 – Candela Corporation, a leading global aesthetic device company, announces that the ProfoundÒ

Read more
Press Releases

Syneron Candela Announces Launch of Direct Operation in Korea

September 30, 2018

Syneron Candela Korea Co. Ltd focused on enhancing Customer Service in Growth Markets

Read more
Press Releases

Candela® And The Vascular Birthmarks Foundation Partner To Provide Pro-Bono Laser Treatments

September 26, 2018
Over 30 pre-qualified patients will receive treatment with the Vbeam Pulsed Dye Laser to commence the Vascular Birthmarks Foundation's 18th Annual Conference.
Read more
Press Releases

Candela Announces Acquisition of Ellipse

September 5, 2018

Acquisition of Danish Ellipse adds globally renowned IPL and laser technologies to Candela’s portfolio, further strengthening their position in multi-application, multi-technology devices

Read more
Press Releases

Candela Announces FDA Clearance of Vbeam® Prima

July 17, 2018

The new Vbeam Prima takes Candela’s “gold standard” 595 nm Pulsed Dye Laser (PDL) platform to the next level

 

Read more
Press Releases

Syneron Candela's PicoWay Picosecond Laser Receives U.S. FDA Clearance for Ultra-Short 785nm Wavelength

July 25, 2016
The PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for a new ultra-short 785nm wavelength, which is the third FDA cleared wavelength for PicoWay.
Read more